Financials
- Market Capitalization 10.44 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3 449
Fiyat/satışlar oranı
5.56
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 878 | KRYS Krystal Biotech, Inc. - Common Stock | 363.44 USD | -0.65% | -3.21% | +11.44% | +94.22% | 10.71 B USD | ||
| 881 | ABVX Abivax SA - American Depositary Shares | 135.98 USD | -2.80% | -4.58% | +36.53% | +1410.89% | 10.68 B USD | ||
| 906 | CYTK Cytokinetics, Incorporated - Common Stock | 82.24 USD | -3.10% | -4.47% | +19.08% | +41.55% | 10.23 B USD | ||
| 924 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.94 USD | +0.03% | +0.19% | +0.47% | +30.53% | 9.79 B USD |